Home › Funds › Rosalind Advisors, Inc. › DCTH
Rosalind Advisors, Inc. position in DCTH
DELCATH SYS INC · Health Care
Rosalind Advisors, Inc. reported holding 3,300,389 shares of DCTH (DELCATH SYS INC) in its Q3 2026 13F filing — a position valued at US$52.7M, representing 21.54% of its reported portfolio and ranking #1 among its reported holdings. Rosalind Advisors, Inc. has disclosed DCTH holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rosalind Advisors, Inc.'s DCTH position evolved
Rosalind Advisors, Inc. first disclosed a stake in DCTH in Q4 2023 at 1,038,828 shares (US$4.3M). The position peaked in Q3 2026 at 3,300,389 shares, worth US$52.7M. Across 12 filings, Rosalind Advisors, Inc. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 3,300,389 shares valued at US$52.7M. Notable position changes include a 155% increase in Q2 2024 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.04M | $4.32M | New |
| Q1 2024 | 1.04M | $4.96M | Hold |
| Q2 2024 | 2.65M | $15.53M | Add |
| Q3 2024 | 2.65M | $21.20M | Hold |
| Q4 2024 | 2.65M | $31.91M | Hold |
| Q1 2025 | 2.90M | $29.00M | Add |
| Q2 2025 | 3.30M | $33.00M | Add |
| Q3 2025 | 3.30M | $33.00M | Hold |
| Q4 2025 | 3.30M | $33.00M | Hold |
| Q1 2026 | 3.30M | $30.63M | Hold |
| Q2 2026 | 3.30M | $41.55M | Hold |
| Q3 2026 | 3.30M | $52.71M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DCTH and 13F data
DCTH (DELCATH SYS INC) is a Health Care company. 43 other funds we track also report a position in DCTH — the largest reported positions include Propel Bio Management, LLC (US$9.7M), Simplify Asset Management Inc. (US$3.6M), Lane Generational LLC (US$2.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DCTH
- Propel Bio Management, LLC 604.66K sh · $9.66M · Q3 2026
- Simplify Asset Management Inc. 227.68K sh · $3.64M · Q3 2026
- Lane Generational LLC 143.97K sh · $2.30M · Q3 2026
More on Rosalind Advisors, Inc.
FAQ
How long has Rosalind Advisors, Inc. held DCTH?
Rosalind Advisors, Inc. has disclosed DCTH holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Rosalind Advisors, Inc.'s current position in DCTH?
As of Q3 2026, Rosalind Advisors, Inc. holds 3.30M shares of DCTH (DELCATH SYS INC), valued at $52.71M, representing 21.54% of its reported portfolio and ranking #1.
Has Rosalind Advisors, Inc. been buying or selling DCTH?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. held unchanged its position in DCTH. The position peaked in Q3 2026 at 3.30M shares.
Which other funds hold DCTH?
Other major institutional holders of DCTH include Propel Bio Management, LLC, Simplify Asset Management Inc., Lane Generational LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.